Category: Cancer

Merck impresses NICE with Keytruda data—and discounts—cueing up a CDF switch

After making headlines at this year’s American Society of Clinical Oncology annual meeting, Merck’s Keytruda had a big week on the other side of the pond, too. On Wednesday, England’s cost-effectiveness gatekeepers at the National Institute for Health and Care Excellence recommended the drug in draft guidance for routine use as a treatment for previously untreated lung cancer.

Roche, GE Partnership to Develop Integrated Digital Diagnostics Platform to Improve Oncology

NewsRoche announced that it has entered into a strategic, long-term partnership with GE Healthcare in order to jointly develop and co-market digital clinical decision support solutions. The partnership will initially focus on products that accelerate and improve individualized treatment options for cancer and critical care patients.Contributed Author: RocheTopics: Disease Research